The Experts below are selected from a list of 8949 Experts worldwide ranked by ideXlab platform
Seungjae Myung - One of the best experts on this subject based on the ideXlab platform.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Seong Eun Kim, Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Tae Hee Lee, Kee Wook Jung, Hoon Sup Koo, Seungjae MyungAbstract:Background/aims We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P Conclusions Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Kee Wook Jung, Seungjae MyungAbstract:Background/aims: We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods: Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results: The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P < 0.001). Relief of subjective CSBM frequency, stool consistency and abdominal bloating were reported in 70%, 60%, and 47% of patients. After VSL#3 cessation, 44.4% of patients with symptom improvement experienced constipation recurrence mostly within one month. Conclusions: Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
Georges K Christophides - One of the best experts on this subject based on the ideXlab platform.
-
melanotic pathology and vertical transmission of the Gut commensal elizabethkingia meningoseptica in the major malaria vector anopheles gambiae
PLOS ONE, 2013Co-Authors: Idir G Akhouayri, Tibebu Habtewold, Georges K ChristophidesAbstract:Background The resident Gut Flora is known to have significant impacts on the life history of the host organism. Endosymbiotic bacterial species in the Anopheles mosquito Gut are potent modulators of sexual development of the malaria parasite, Plasmodium, and thus proposed as potential control agents of malaria transmission.
-
melanotic pathology and vertical transmission of the Gut commensal elizabethkingia meningoseptica in the major malaria vector anopheles gambiae
PLOS ONE, 2013Co-Authors: Idir G Akhouayri, Tibebu Habtewold, Georges K ChristophidesAbstract:Background The resident Gut Flora is known to have significant impacts on the life history of the host organism. Endosymbiotic bacterial species in the Anopheles mosquito Gut are potent modulators of sexual development of the malaria parasite, Plasmodium, and thus proposed as potential control agents of malaria transmission.
Suck Chei Choi - One of the best experts on this subject based on the ideXlab platform.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Seong Eun Kim, Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Tae Hee Lee, Kee Wook Jung, Hoon Sup Koo, Seungjae MyungAbstract:Background/aims We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P Conclusions Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Kee Wook Jung, Seungjae MyungAbstract:Background/aims: We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods: Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results: The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P < 0.001). Relief of subjective CSBM frequency, stool consistency and abdominal bloating were reported in 70%, 60%, and 47% of patients. After VSL#3 cessation, 44.4% of patients with symptom improvement experienced constipation recurrence mostly within one month. Conclusions: Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
Kyung Sik Park - One of the best experts on this subject based on the ideXlab platform.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Seong Eun Kim, Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Tae Hee Lee, Kee Wook Jung, Hoon Sup Koo, Seungjae MyungAbstract:Background/aims We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P Conclusions Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Kee Wook Jung, Seungjae MyungAbstract:Background/aims: We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods: Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results: The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P < 0.001). Relief of subjective CSBM frequency, stool consistency and abdominal bloating were reported in 70%, 60%, and 47% of patients. After VSL#3 cessation, 44.4% of patients with symptom improvement experienced constipation recurrence mostly within one month. Conclusions: Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
Moo In Park - One of the best experts on this subject based on the ideXlab platform.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Seong Eun Kim, Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Tae Hee Lee, Kee Wook Jung, Hoon Sup Koo, Seungjae MyungAbstract:Background/aims We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P Conclusions Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.
-
change of fecal Flora and effectiveness of the short term vsl 3 probiotic treatment in patients with functional constipation
Journal of Neurogastroenterology and Motility, 2015Co-Authors: Suck Chei Choi, Kyung Sik Park, Moo In Park, Jeong Eun Shin, Kee Wook Jung, Seungjae MyungAbstract:Background/aims: We investigated Gut Flora characteristics in patients with functional constipation (FC) and influences of short-term treatment with VSL#3 probiotic on Flora and symptom improvement. Methods: Thirty patients fulfilling Rome III criteria for FC and 30 controls were enrolled. Fecal samples were obtained before and after VSL#3 intake (one sachet twice daily for 2 weeks) and Flora were examined by quantitative real-time polymerase chain reaction (qRT-PCR). Symptom changes were also investigated. Results: The fold differences in Bifidobacterium and Bacteroides species were significantly lower in feces from FC, compared to in controls (P = 0.030 and P = 0.021). After taking VSL#3, the fold differences in Lactobacillus, Bifidobacterium and Bacteroides species increased in controls (P = 0.022, P = 0.018, and P = 0.076), but not in FC. Mean Bristol scores and complete spontaneous bowel movements (CSBMs)/week increased significantly in FC after ingesting VSL#3 (both P < 0.001). Relief of subjective CSBM frequency, stool consistency and abdominal bloating were reported in 70%, 60%, and 47% of patients. After VSL#3 cessation, 44.4% of patients with symptom improvement experienced constipation recurrence mostly within one month. Conclusions: Bifidobacterium and Bacteroides species might be quantitatively altered in FC. A short-term VSL#3 treatment can improve clinical symptoms of FC. Further studies are needed to investigate VSL#3's additional effects beyond altering Gut Flora to allevate constipation.